Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Autologous anti-HLA-A2/NY-ESO-1 TCR T cells |
Trade Name | |
Synonyms | A2-ESO-1 TCR-T cells |
Drug Descriptions |
Autologous anti-HLA-A2/NY-ESO-1 TCR T cells are T-lymphocytes engineered to express a T-cell receptor (TCR) targeting HLA-A2/NY-ESO-1 expressed on tumor cells, which potentially induce killing of tumor cells expressing NY-ESO-1 (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C122679 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Autologous anti-HLA-A2/NY-ESO-1 TCR T cells | Autologous anti-HLA-A2/NY-ESO-1 TCR T cells | 0 | 1 |